Indication
Malignant Glioma of Brain
5 clinical trials
6 products
1 drug
Clinical trial
Phase I Study of Replication-Competent Adenovirus-Mediated Double Suicide Gene Therapy With Stereotactic Radiosurgery in Patients With Recurrent or Progressive High Grade AstrocytomasStatus: Recruiting, Estimated PCD: 2024-10-01
Product
Ad5-yCD/mutTKSR39rep-ADPClinical trial
Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade GliomaStatus: Not yet recruiting, Estimated PCD: 2028-12-02
Product
Biological G207Clinical trial
A Phase III Clinical Trial of Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic AcidStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
5 Aminolevulinic AcidClinical trial
A Phase I Study of Safety and Tolerability of Acetazolamide With Temozolomide in Adults With Newly Diagnosed MGMT Promoter-Methylated IDH Wildtype GlioblastomaStatus: Recruiting, Estimated PCD: 2026-10-01
Product
AcetazolamideClinical trial
A Phase I Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation With CyclophosphamideStatus: Recruiting, Estimated PCD: 2024-12-01
Product
rQNestinDrug
cyclophosphamideProduct
TMZ